Everus Construction Group Statistics
Total Valuation
ECG has a market cap or net worth of $4.45 billion. The enterprise value is $4.91 billion.
| Market Cap | 4.45B |
| Enterprise Value | 4.91B |
Important Dates
The last earnings date was Tuesday, November 3, 2026, after market close.
| Earnings Date | Nov 3, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ECG has 51.06 million shares outstanding. The number of shares has increased by 0.06% in one year.
| Current Share Class | 51.06M |
| Shares Outstanding | 51.06M |
| Shares Change (YoY) | +0.06% |
| Shares Change (QoQ) | +0.04% |
| Owned by Insiders (%) | 0.31% |
| Owned by Institutions (%) | 88.30% |
| Float | 50.86M |
Valuation Ratios
The trailing PE ratio is 15.43 and the forward PE ratio is 12.60. ECG's PEG ratio is 0.57.
| PE Ratio | 15.43 |
| Forward PE | 12.60 |
| PS Ratio | 0.95 |
| Forward PS | 0.76 |
| PB Ratio | 5.15 |
| P/TBV Ratio | 15.66 |
| P/FCF Ratio | 18.75 |
| P/OCF Ratio | 14.11 |
| PEG Ratio | 0.57 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.55, with an EV/FCF ratio of 20.68.
| EV / Earnings | 16.96 |
| EV / Sales | 1.05 |
| EV / EBITDA | 11.55 |
| EV / EBIT | 12.83 |
| EV / FCF | 20.68 |
Financial Position
The company has a current ratio of 1.53, with a Debt / Equity ratio of 0.81.
| Current Ratio | 1.53 |
| Quick Ratio | 1.43 |
| Debt / Equity | 0.81 |
| Debt / EBITDA | 1.14 |
| Debt / FCF | 2.96 |
| Interest Coverage | 18.76 |
Financial Efficiency
Return on equity (ROE) is 40.26% and return on invested capital (ROIC) is 24.85%.
| Return on Equity (ROE) | 40.26% |
| Return on Assets (ROA) | 11.05% |
| Return on Invested Capital (ROIC) | 24.85% |
| Return on Capital Employed (ROCE) | 24.60% |
| Weighted Average Cost of Capital (WACC) | 15.76% |
| Revenue Per Employee | $496,192 |
| Profits Per Employee | $30,787 |
| Employee Count | 9,400 |
| Asset Turnover | 2.15 |
| Inventory Turnover | 71.59 |
Taxes
In the past 12 months, ECG has paid $97.76 million in taxes.
| Income Tax | 97.76M |
| Effective Tax Rate | 25.25% |
Stock Price Statistics
The stock price has decreased by -12.84% in the last 52 weeks. The beta is 2.48, so ECG's price volatility has been higher than the market average.
| Beta (5Y) | 2.48 |
| 52-Week Price Change | -12.84% |
| 50-Day Moving Average | 109.28 |
| 200-Day Moving Average | 125.67 |
| Relative Strength Index (RSI) | 40.84 |
| Average Volume (20 Days) | 995,708 |
Short Selling Information
The latest short interest is 2.04 million, so 4.00% of the outstanding shares have been sold short.
| Short Interest | 2.04M |
| Short Previous Month | 1.78M |
| Short % of Shares Out | 4.00% |
| Short % of Float | 4.01% |
| Short Ratio (days to cover) | 4.67 |
Income Statement
In the last 12 months, ECG had revenue of $4.66 billion and earned $289.40 million in profits. Earnings per share was $5.65.
| Revenue | 4.66B |
| Gross Profit | 636.15M |
| Operating Income | 382.63M |
| Pretax Income | 387.16M |
| Net Income | 289.40M |
| EBITDA | 425.21M |
| EBIT | 382.63M |
| Earnings Per Share (EPS) | $5.65 |
Balance Sheet
The company has $245.14 million in cash and $703.34 million in debt, with a net cash position of -$458.20 million or -$8.97 per share.
| Cash & Cash Equivalents | 245.14M |
| Total Debt | 703.34M |
| Net Cash | -458.20M |
| Net Cash Per Share | -$8.97 |
| Equity (Book Value) | 864.50M |
| Book Value Per Share | 16.93 |
| Working Capital | 612.35M |
Cash Flow
In the last 12 months, operating cash flow was $315.50 million and capital expenditures -$78.15 million, giving a free cash flow of $237.35 million.
| Operating Cash Flow | 315.50M |
| Capital Expenditures | -78.15M |
| Depreciation & Amortization | 42.58M |
| Net Borrowing | 260.52M |
| Free Cash Flow | 237.35M |
| FCF Per Share | $4.65 |
Margins
Gross margin is 13.64%, with operating and profit margins of 8.20% and 6.20%.
| Gross Margin | 13.64% |
| Operating Margin | 8.20% |
| Pretax Margin | 8.30% |
| Profit Margin | 6.20% |
| EBITDA Margin | 9.12% |
| EBIT Margin | 8.20% |
| FCF Margin | 5.09% |
Dividends & Yields
ECG does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.06% |
| Shareholder Yield | -0.06% |
| Earnings Yield | 6.48% |
| FCF Yield | 5.33% |
Analyst Forecast
The average price target for ECG is $146.83, which is 68.44% higher than the current price. The consensus rating is "Buy".
| Price Target | $146.83 |
| Price Target Difference | 68.44% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | 20.77% |
| EPS Growth Forecast (3Y) | 29.61% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ECG has an Altman Z-Score of 4.77 and a Piotroski F-Score of 5.
| Altman Z-Score | 4.77 |
| Piotroski F-Score | 5 |